NCT01814137 - A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

For subcutaneous (s.c., under the skin) administration twice daily in combination with up to 2 oral antidiabetic drugs (OADs- dose and dosing frequency of OAD should remain unchanged).

DRUG

insulin degludec

For subcutaneous (s.c., under the skin) administration once daily in combination with up to 2 oral antidiabetic drugs (OADs- dose and dosing frequency of OAD should remain unchanged).

DRUG

insulin aspart

For subcutaneous (s.c., under the skin) administration once daily. Dose of IDegAsp and IAsp are individually adjusted.

DRUG

insulin aspart

For subcutaneous (s.c., under the skin) administration three times a day. Dose of IDeg and IAsp are individually adjusted.

Trial Locations (40)

12206

Novo Nordisk Investigational Site, Albany

16000

Novo Nordisk Investigational Site, Algiers

16015

Novo Nordisk Investigational Site, Tizi Ouzou

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

20070

Novo Nordisk Investigational Site, Denizli

27070

Novo Nordisk Investigational Site, Gaziantep

29572

Novo Nordisk Investigational Site, Myrtle Beach

31000

Novo Nordisk Investigational Site, Oran

31040

Novo Nordisk Investigational Site, Hatay

33324

Novo Nordisk Investigational Site, Plantation

34201

Novo Nordisk Investigational Site, Bradenton

34741

Novo Nordisk Investigational Site, Kissimmee

34752

Novo Nordisk Investigational Site, Istanbul

46123

Novo Nordisk Investigational Site, Avon

46150

Novo Nordisk Investigational Site, Kuala Selangor

46254

Novo Nordisk Investigational Site, Indianapolis

48145

Novo Nordisk Investigational Site, Münster

49620

Novo Nordisk Investigational Site, Buckley

53142

Novo Nordisk Investigational Site, Kenosha

56564

Novo Nordisk Investigational Site, Neuwied

60012

Novo Nordisk Investigational Site, Crystal Lake

66386

Novo Nordisk Investigational Site, Saint Ingbert

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

71729

Novo Nordisk Investigational Site, Erdmannhausen

75230

Novo Nordisk Investigational Site, Dallas

75251

Novo Nordisk Investigational Site, Dallas

76132

Novo Nordisk Investigational Site, Fort Worth

85020

Novo Nordisk Investigational Site, Phoenix

85395

Novo Nordisk Investigational Site, Goodyear

91978

Novo Nordisk Investigational Site, Spring Valley

92111

Novo Nordisk Investigational Site, San Diego

92801

Novo Nordisk Investigational Site, Anaheim

94904

Novo Nordisk Investigational Site, Greenbrae

98405

Novo Nordisk Investigational Site, Tacoma

98502

Novo Nordisk Investigational Site, Olympia

70461-4231

Novo Nordisk Investigational Site, Slidell

02453

Novo Nordisk Investigational Site, Waltham

03063

Novo Nordisk Investigational Site, Nashua

08648

Novo Nordisk Investigational Site, Lawrenceville

08755-8050

Novo Nordisk Investigational Site, Toms River